跳轉至內容
Merck
全部照片(2)

Key Documents

917230

Sigma-Aldrich

NanoFabTx™ device accessory

interface H

同義詞:

Microfluidic kit, NanoFabTx™, Nanoformulation

登入查看組織和合約定價
全部照片(2)

About This Item

分類程式碼代碼:
41121800
NACRES:
NA.23

描述

Microfludic hardware kit component
Kit components : Inerface H x 1

品質等級

100

應用

advanced drug delivery

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

NanoFabTx™ device accessory, interface H is a component of our NanoFabTx™ microfluidic device kits (911593, 911879). The kits additionally include a protocol, microfluidic chip, connectors, tubing, and additional accessories for microfluidic-based synthesis.

應用

NanoFabTx™ device accessory, interface H facilitates fluidic connections from two linear connectors to the microfluidic chip. NanoFabTx™ device accessory, interface H can be used as a replacement for the component in our NanoFabTx™ microfluidic device kits (911593, 911879).

法律資訊

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

相關產品

產品號碼
描述
訂價

911593

NanoFabTx™ 微流体 - 纳米, device kit for synthesis of 100-200 nm nanoparticles and liposomes

911860

NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles

911879

NanoFabTx™ microfluidic - micro, device kit for synthesis of 10-30 μm particles

909637

NanoFabTx™ PLGA-nano, for synthesis of 100 and 200 nm particles

912212

NanoFabTx™ PLGA-micro, for synthesis of 10-30 um particles

912220

NanoFabTx™ PLGA-micro, for synthesis of 1-5 μm particles

920436

NanoFabTx™ PEG-PLA drug formulation screening kit, for synthesis of PEGylated nanoparticles

915408

NanoFabTx™ PEGylated nanoparticle formulation screening kit

917796

NanoFabTx™ PEG-PLGA drug formulation screening kit, for synthesis of PEGylated nanoparticles

918881

NanoFabTx™ PEG-PCL drug formulation screening kit, for synthesis of PEGylated nanoparticles

918075

NanoFabTx™ PLA-nano, for synthesis of 100 and 200 nm particles

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

抱歉，我們目前沒有在線上提供本產品的COA

如果您需要協助，請聯絡 客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務